FIM
IRD

Frontier Investment Management’s Opus Genetics IRD Stock Holding History

Frontier Investment Management’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-833
Closed -$20K – 287
2019
Q1 		$20K Buy
833
+416
+100% +$13.8K ﹤0.01% 253
2018
Q4 		$19K Buy
+417
New +$24.4K ﹤0.01% 243

Other funds holding IRD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Frontier Investment Management's IRD Position: Q2 2019 in Review

Frontier Investment Management sold out of Opus Genetics (IRD) in Q2 2019, closing a stake of 833 shares — an estimated $20K sold.

Frontier Investment Management first reported a position in IRD in Q4 2018 and held it in 2 quarters. The position peaked at $20K in Q1 2019. 16 funds tracked by Wall St. Rank hold IRD as of Q2 2019.

  • Frontier Investment Management reported no remaining Opus Genetics position as of Q2 2019 after selling out during the quarter.
  • Frontier Investment Management sold 833 Opus Genetics shares in Q2 2019, an estimated $20K.
  • Frontier Investment Management first reported a position in Opus Genetics in Q4 2018 and held it in 2 quarters.
  • Frontier Investment Management's Opus Genetics position peaked at $20K in Q1 2019.
  • 16 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2019.

Based on Frontier Investment Management's 13F filing for Q2 2019, filed 13 Aug 2019.